|
1
|
Bertuccio P, Chatenoud L, Levi F, Praud D,
Ferlay J, Negri E, Malvezzi M and La Vecchia C: Recent patterns in
gastric cancer: A global overview. Int J Cancer. 125:666–673. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cha Y, He Y, Ouyang K, Xiong H, Li J and
Yuan X: MicroRNA-140-5p suppresses cell proliferation and invasion
in gastric cancer by targeting WNT1 in the WNT/β-catenin signaling
pathway. Oncol Lett. 16:6369–6376. 2018.PubMed/NCBI
|
|
3
|
Hamashima C: Current issues and future
perspectives of gastric cancer screening. World J Gastroenterol.
20:13767–13774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He Z, Wang X, Huang C, Gao Y, Yang C, Zeng
P and Chen Z: The FENDRR/miR-214-3P/TET2 axis affects cell
malignant activity via RASSF1A methylation in gastric cancer. Am J
Transl Res. 10:3211–3223. 2018.PubMed/NCBI
|
|
5
|
Yang Y, Shen J, Yan D, Yuan B, Zhang S,
Wei J and Du T: Euchromatic histone lysine methyltransferase 1
regulates cancer development in human gastric cancer by regulating
E-cadherin. Oncol Lett. 15:9480–9486. 2018.PubMed/NCBI
|
|
6
|
Correa P: Gastric cancer: Overview.
Gastroenterol Clin North Am. 42:211–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shin VY, Ng EK, Chan VW, Kwong A and Chu
KM: A three-miRNA signature as promising non-invasive diagnostic
marker for gastric cancer. Mol Cancer. 14:2022015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu HH, Lin WC and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang LK, Xie XN, Song XH, Su T, Chang XL,
Xu M, Liang B and Huang DY: Upregulation of miR-200b inhibits
hepatocellular carcinoma cell proliferation and migration by
targeting HMGB3 protein. Technol Cancer Res Treat.
17:15330338188064752018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lan H, Lu H, Wang X and Jin H: MicroRNAs
as potential biomarkers in cancer: Opportunities and challenges.
Biomed Res Int. 2015:1250942015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Van Schooneveld E, Wildiers H, Vergote I,
Vermeulen PB, Dirix LY and Van Laere SJ: Dysregulation of microRNAs
in breast cancer and their potential role as prognostic and
predictive biomarkers in patient management. Breast Cancer Res.
17:212015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Zhang S, Bao H, Mu S, Zhang B, Ma
H and Ma S: MicroRNA-365 promotes lung carcinogenesis by
downregulating the USP33/SLIT2/ROBO1 signaling pathway. Cancer Cell
Int. 18:642018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu HS and Xiao HS: MicroRNAs as potential
biomarkers for gastric cancer. World J Gastroenterol.
20:12007–12017. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang M, Gu H, Qian H, Zhu W, Zhao C, Zhang
X, Tao Y, Zhang L and Xu W: miR-17-5p/20a are important markers for
gastric cancer and murine double minute 2 participates in their
functional regulation. Eur J Cancer. 49:2010–2021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun C, Yao X, Jiang Q and Sun X: miR-106b
targets DAB2 to promote hepatocellular carcinoma cell proliferation
and metastasis. Oncol Lett. 16:3063–3069. 2018.PubMed/NCBI
|
|
17
|
Liu LJ, Yu JJ and Xu XL: MicroRNA-93
inhibits apoptosis and promotes proliferation, invasion and
migration of renal cell carcinoma ACHN cells via the TGF-β/Smad
signaling pathway by targeting RUNX3. Am J Transl Res. 9:3499–3513.
2017.PubMed/NCBI
|
|
18
|
Yan H, Li Q, Wu J, Hu W, Jiang J, Shi L,
Yang X, Zhu D, Ji M and Wu C: MiR-629 promotes human pancreatic
cancer progression by targeting FOXO3. Cell Death Dis. 8:e31542017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Di Vincenzo S, Heijink IH, Noordhoek JA,
Cipollina C, Siena L, Bruno A, Ferraro M, Postma DS, Gjomarkaj M
and Pace E: SIRT1/FoxO3 axis alteration leads to aberrant immune
responses in bronchial epithelial cells. J Cell Mol Med.
22:2272–2282. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim SY, Kim HJ, Byeon HK, Kim DH and Kim
CH: FOXO3 induces ubiquitylation of AKT through MUL1 regulation.
Oncotarget. 8:110474–110489. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu S, Yu Y, Zhang W, Yuan W, Zhao N, Li Q,
Cui Y, Wang Y, Li W, Sun Y and Liu T: FOXO3a promotes gastric
cancer cell migration and invasion through the induction of
cathepsin L. Oncotarget. 7:34773–34784. 2016.PubMed/NCBI
|
|
22
|
Park SH, Jang KY, Kim MJ, Yoon S, Jo Y,
Kwon SM, Kim KM, Kwon KS, Kim CY and Woo HG: Tumor suppressive
effect of PARP1 and FOXO3A in gastric cancers and its clinical
implications. Oncotarget. 6:44819–44831. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiong H, Wang J, Guan H, Wu J, Xu R, Wang
M, Rong X, Huang K, Huang J, Liao Q, et al: SphK1 confers
resistance to apoptosis in gastric cancer cells by downregulating
Bim via stimulating Akt/FoxO3a signaling. Oncol Rep. 32:1369–1373.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ho KK, Myatt SS and Lam EW: Many forks in
the path: Cycling with FoxO. Oncogene. 27:2300–2311. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hagenbuchner J, Kuznetsov A, Hermann M,
Hausott B, Obexer P and Ausserlechner MJ: FOXO3-induced reactive
oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell
Sci. 125:1191–1203. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Essers MA, Weijzen S, de Vries-Smits AM,
Saarloos I, de Ruiter ND, Bos JL and Burgering BM: FOXO
transcription factor activation by oxidative stress mediated by the
small GTPase Ral and JNK. EMBO J. 23:4802–4812. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Tang N, Hadden TJ and Rishi AK:
Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta.
1813:1978–1986. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dall' Acqua A, Sonego M, Pellizzari I,
Pellarin I, Canzonieri V, D'Andrea S, Benevol S, Sorio R, Giorda G,
Califano D, et al: CDK6 protects epithelial ovarian cancer from
platinum-induced death via FOXO3 regulation. EMBO Mol Med.
9:1415–1433. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang F, Xu Y, Liu C, Ma C, Zou S, Xu X,
Jia J and Liu Z: NF-κB/miR-223-3p/ARID1A axis is involved in
Helicobacter pylori CagA-induced gastric carcinogenesis and
progression. Cell Death Dis. 9:122018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu X, Gao F, Wang J, Tao L, Ye J, Ding L,
Ji W and Chen X: MiR-122-5p inhibits cell migration and invasion in
gastric cancer by down-regulating DUSP4. Cancer Biol Ther.
19:427–435. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feng Q, He P and Wang Y: MicroRNA-223-3p
regulates cell chemo-sensitivity by targeting FOXO3 in prostatic
cancer. Gene. 658:152–158. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang N, Zhang J, Qin M, Yi W, Yu S, Chen
Y, Guan J and Zhang R: Amelioration of streptozotocin-induced
pancreatic β cell damage by morin: Involvement of the
AMPK-FOXO3-catalase signaling pathway. Int J Mol Med. 41:1409–1418.
2018.PubMed/NCBI
|
|
34
|
Li J, Li P, Chen T, Gao G, Chen X, Du Y,
Zhang R, Yang R, Zhao W, Dun S, et al: Expression of microRNA-96
and its potential functions by targeting FOXO3 in non-small cell
lung cancer. Tumour Biol. 36:685–692. 2015. View Article : Google Scholar : PubMed/NCBI
|
